Fondazione Humanitas Per La Ricerca Ets

The oncology unit at Fondazione Humanitas Per La Ricerca Ets focuses on Neoplasms, specifically Non‑Small Cell Lung Cancer, evaluating new combination regimens to improve tumor response rates.

• Assessing objective response rate of investigational agents with standard chemotherapy
• Evaluating safety and tolerability of platinum‑doublet chemotherapy plus novel therapies
• Exploring first‑line treatment benefits for locally advanced or metastatic disease

These studies aim to expand therapeutic options for patients with advanced lung cancer and support the site’s mission to advance cancer care.

Research at the lung cancer service investigates Neoplasms in Non‑Small Cell Lung Cancer patients, seeking the most effective treatment sequencing based on molecular subtypes.

• Progression‑free survival as the primary efficacy endpoint
• Stratification of patients by oncogenic driver alterations
• Comparative analysis of sequential therapeutic arms

The goal is to define personalized treatment pathways that maximize outcomes for individuals with targetable genomic profiles.